Relay Therapeutics, Inc. RLAY Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3M-57.1% | $7M— | $0-100% | $677K-91.2% | $7.68M— | ||
| $70.56M+27.3% | $55.42M-18.8% | $68.26M+6.8% | $63.9M-13.4% | $73.81M+8.4% | ||
| $11.03M-9.7% | $12.22M+0.7% | $12.13M-11.0% | $13.63M-27.3% | $18.74M+10.9% | ||
| $81.59M+20.6% | $67.63M-15.9% | $80.39M+3.7% | $77.52M-16.2% | $92.55M+8.9% | ||
| -$78.59M-29.6% | -$60.63M+24.6% | -$80.39M-4.6% | -$76.85M+9.5% | -$84.87M+0.1% | ||
| -2,619.7%-1,754pp | -866.1%— | —— | -11,351.1%-10,246pp | -1,105.2%— | ||
| $5.3M-7.7% | $5.74M-8.0% | $6.24M-3.6% | $6.47M-17.1% | $7.8M-13.0% | ||
| -$73.29M-33.5% | -$54.89M+26.0% | -$74.15M-5.4% | -$70.38M+8.7% | -$77.07M-1.4% | ||
| -2,443%-1,659pp | -784.1%— | —— | -10,395.1%-9,392pp | -1,003.6%— | ||
| -$0.41-32.3% | -$0.31+27.9% | -$0.43-4.9% | -$0.41+10.9% | -$0.46-9.5% | ||
| -$78.09M-30.1% | -$60.03M+24.6% | -$79.64M-5.0% | -$75.85M+9.3% | -$83.66M0.0% | ||
| -2,602.9%-1,745pp | -857.6%— | —— | -11,203.1%-10,114pp | -1,089.5%— | ||
| -$78.59M-29.6% | -$60.63M+24.6% | -$80.39M-4.6% | -$76.85M+9.5% | -$84.87M+0.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Relay Therapeutics, Inc.'s revenue?
- Relay Therapeutics, Inc. (RLAY) generated $10.7M in revenue over the trailing twelve months, up 39.0% year over year.
- Is Relay Therapeutics, Inc. profitable?
- Relay Therapeutics, Inc. is not currently profitable: it reported a net loss of $272.7M over the trailing twelve months, a -2554.1% net margin.
- What is Relay Therapeutics, Inc.'s earnings per share?
- Relay Therapeutics, Inc.'s diluted EPS over the trailing twelve months is $-1.56.
- Where does Relay Therapeutics, Inc.'s income statement data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
